KCR 2026

English is the official language for abstract submission, presentation materials, and presentations.

• All abstracts must be submitted via the Online System only.
• The abstract submitter must choose one topic from the category.
• Submitting an abstract does not automatically register you for KCR 2026. Please ensure that all abstract presenters also complete the registration process.
• Authors can modify their abstracts before the submission deadline (January 5 (Mon.), 2026) on the website.
• When you submit your abstract online, your abstract will be automatically edited according to KCR 2026 submission formats.
• It is the authors' responsibility to review the submissions and correct them. Submitters are responsible for all typing errors in the abstract.
• The submission form is intended for the review of the abstract.
• A confirmation letter of abstract submission will be automatically sent to the submitter and corresponding author by e-mail upon the completion of the online submission.

• An encore presentation is one where you have already presented the submitted work before.
• Encore presentations are permitted as long as work has been presented after the last KCR (May 15 (Thu.) – 17 (Fri.), 2025) when you have presented the work at another academic conference.
• Encore presentations are permitted as long as work has not previously been published prior to submission.
• Publication in a print or online journal of the abstract in a scientific journal after the submission deadline is not in conflict with presenting it at KCR 2026.
• Abstracts published before the abstract review cannot be submitted.
• When the abstract is found that it has been published or posted in an online journal before the abstract review, it will be excluded from the review.
• Encore submissions must disclose the name and date of the meeting at which they were presented if they are updated or enhanced (e.g. added number or method of analysis, etc.).
• Encore submissions must disclose the name and date of the meeting at which they were presented if they are updated or enhanced such as added number or method of analysis, etc. (e.g. "This abstract was presented previously in ACR 2023 conference, at Oct - 2023.").

• Communication and/or dissemination of abstracts and information contained therein intended for presentations and/or lectures at the KCR 2026 is prohibited during the embargo period, i.e. starting from the date of acceptance notice until the start of each individual presentation. After the presentation, KCR will allow dissemination and submission to any other third party.
• KCR 2026’s permission is required prior to dissemination and/or submission to any other third party. In case of any violation of the above-stated policies, KCR 2026, the copyright holder, reserves the right to take appropriate action, including withdrawal of the concerned abstract.

If there are relevant financial activities outside the submitted work, the submitter, who is entrusted by all the co-authors, must complete a disclosure form for potential conflict of interest when they submit their abstract. A conflict of interest may exist when an author (or author's institution or employer) has financial or personal relationships or affiliations that could influence (or bias) the author's decisions, work, or abstract. Please fill out the Conflict-of-Interest Disclosure Form and send it to the KCR 2026 Secretariat via email, program@kcr2026.com.

“Basic Science and Immunology Related to Rheumatic Diseases” is not provided as a separate category. Please submit basic or translational abstracts under the single clinical, disease-based category (1–15) that best matches the main disease focus of your study.

All submitted abstracts will be reviewed by the Academic Affairs committee according to the review process.

The presenting author whose abstract has been accepted needs to register with full payment for the meeting to confirm their participation by the deadline, March 9 (Mon.), 2026.